Targeting the PI3K-AKT-mTOR signaling network in cancer

Por Khan, Khurum H., Yap, Timothy A., Yan, Li, Cunningham, David
Publicado em 2013

Assessment of fertility control efforts in a selected area of Karachi, Pakistan

Por Shirmeen, Amra, Khan, Muhammad FH, Khan, Khizer H, Khan, Khurum H
Publicado em 2007

Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Mana...

Por Khan, Khurum H., Wong, Mabel, Rihawi, Karim, Bodla, Shankar, Morganstein, Daniel, Banerji, Udai, Molife, Lulama R.
Publicado no Oncologist (2016)

Longitudinal liquid biopsy and mathematical modelling of clonal evolution forecast waiting time to treatment failure in the PROSPECT-C phase II colorectal cancer clinical trial

Por Khan, Khurum H, Cunningham, David, Werner, Benjamin, Vlachogiannis, Georgios, Spiteri, Inmaculada, Heide, Timon, Mateos, Javier Fernandez, Vatsiou, Alexandra, Lampis, Andrea, Damavandi, Mahnaz Darvish, Lote, Hazel, Huntingford, Ian S., Hedayat, Somaieh, Chau, Ian, Tunariu, Nina, Mentrasti, Giulia, Trevisani, Francesco, Rao, Sheela, Anandappa, Gayathri, Watkins, David, Starling, Naureen, Thomas, Janet, Peckitt, Clare, Khan, Nasir, Rugge, Massimo, Begum, Ruwaida, Hezelova, Blanka, Bryant, Annette, Jones, Thomas, Proszek, Paula, Fassan, Matteo, Hahne, Jens C, Hubank, Michael, Braconi, Chiara, Sottoriva, Andrea, Valeri, Nicola
Publicado no Cancer Discov (2018)